Top

Gepubliceerd in:

01-02-2015 | Original Article

Group Metacognitive Therapy for Severe Antidepressant and CBT Resistant Depression: A Baseline-Controlled Trial

Auteurs: Costas Papageorgiou, Adrian Wells

Gepubliceerd in: Cognitive Therapy and Research | Uitgave 1/2015

Abstract

A significant proportion of individuals experience treatment-resistant depression, defined as a lack of or limited response to current recommended treatments. This study evaluated the effectiveness of group metacognitive therapy (GMCT) for patients who had not responded to both antidepressants and cognitive-behaviour therapy. Following a no-treatment baseline monitoring period, ten patients received 12 2-h weekly sessions, two post-treatment booster sessions and were followed up at 6 months. All of the patients completed GMCT, suggesting that this treatment was acceptable. GMCT was associated with significant improvements across measures of depression, anxiety, rumination, and positive and negative metacognitive beliefs about rumination. These gains were maintained at follow-up. Analyses of rates of recovery revealed that 70 % of patients were classified as recovered and a further 20 % as improved at both post-treatment and 6 months follow-up. There were also reductions in the frequency of comorbid diagnoses. This preliminary study supports further research into GMCT for treatment-resistant depression as a potential clinical and cost effective intervention.

vorige artikel A Randomised Controlled Study of the Effects of the Attention Training Technique on Traumatic Stress Symptoms, Emotional Attention Set Shifting and Flexibility

volgende artikel How to Deal with Negative Thoughts? A Preliminary Comparison of Detached Mindfulness and Thought Evaluation in Socially Anxious Individuals

American Psychiatric Association. (1994). Diagnostic and statistical manual of mental disorders (4th ed.). Washington, DC: Author.

American Psychological Association (1993). Task force on promotion and dissemination of psychological procedures. A report to the Division 12 Board of the American Psychological Association.

Beck, A. T., Epstein, N., Brown, G., & Steer, R. A. (1988). An inventory for measuring clinical anxiety: Psychometric properties. Journal of Consulting and Clinical Psychology, 56, 893–897.PubMedCrossRef

Beck, A. T., Ward, C. H., Mendelson, M., Mock, J., & Erbaugh, J. (1961). An inventory for measuring depression. Archives of General Psychiatry, 4, 561–571.PubMedCrossRef

Ciesla, J. A., & Roberts, J. E. (2002). Self-directed thought and response to treatment for depression: A preliminary investigation. Journal of Cognitive Psychotherapy: An International Quarterly, 16, 435–453.CrossRef

Cornwall, P. L., & Scott, J. (1997). Partial remission in depressive disorders. Acta Psychiatrica Scandinavica, 95, 265–271.PubMedCrossRef

Dammen, T., Papageorgiou, C., & Wells, A. (in press). An open trial of group metacognitive therapy for depression in Norway. Nordic Journal of Psychiatry.

DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., et al. (2005). Cognitive therapy vs. medications in the treatment of moderate to severe depression. Archives of General Psychiatry, 62, 409–416.PubMedCrossRef

Dimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., et al. (2006). Randomized trial of behavioral activation, cognitive therapy and antidepressant medication in the acute treatment of adults with major depression. Journal of Consulting and Clinical Psychology, 74, 658–670.PubMedCrossRef

First, M. B., Spitzer, R. L., Gibbon, M., & Williams, J. B. W. (1997). Structured clinical interview for DSM-IV axis I disorders—Patient edition (SCID-I/P). New York: Biometrics Research Department, New York State Psychiatric Institute.

Frank, E., Prien, R. F., Jarrett, R. B., Keller, M. B., Kupfer, D. J., Lavori, P. W., et al. (1991). Conceptualization and rationale for consensus definitions of terms in major depressive disorder: Remission, recovery, relapse and recurrence. Archives of General Psychiatry, 48, 851–855.PubMedCrossRef

Goring, H. J., & Papageorgiou, C. (2008). Rumination and worry: Factor analysis of self-report measures in depressed participants. Cognitive Therapy and Research, 32, 554–566.CrossRef

Gortner, E. T., Gollan, J. K., Dobson, K. S., & Jacobsen, N. S. (1998). Cognitive-behavioral treatment for depression: Relapse prevention. Journal of Consulting and Clinical Psychology, 66, 377–384.PubMedCrossRef

Hollon, S. D., DeRubeis, R. J., Shelton, R. C., Amsterdam, J. D., Salomon, R. M., O’Reardon, J. P., et al. (2005). Prevention of relapse following cognitive therapy vs. medications in moderate to severe depression. Archives of General Psychiatry, 62, 417–422.PubMedCrossRef

Jones, N. P., Siegle, G. J., & Thase, M. E. (2008). Effects of rumination and initial severity on remission to cognitive therapy for depression. Cognitive Therapy and Research, 32, 591–604.CrossRef

Just, N., & Alloy, L. B. (1997). The response styles theory of depression: Tests and an extension of the theory. Journal of Abnormal Psychology, 106, 221–229.PubMedCrossRef

Keller, M. B., McCullough, J. P., Klein, D. N., Arnow, B., Dunner, D. L., Gelenberg, A. J., et al. (2000). A comparison of nefazodone, the cognitive-behavioral analysis system of psychotherapy, and their combination for the treatment of chronic depression. New England Journal of Medicine, 342, 1462–1470.PubMedCrossRef

Kuehner, C., & Weber, I. (1999). Responses to depression in unipolar depressed patients: An investigation of Nolen-Hoeksema’s response styles theory. Psychological Medicine, 29, 1323–1333.PubMedCrossRef

Lyubomirsky, S., & Tkach, C. (2004). The consequences of dysphoric rumination. In C. Papageorgiou & A. Wells (Eds.), Depressive rumination: Nature, theory and treatment (pp. 21–41). Chichester: Wiley.

Michalak, J., Hölz, A., & Teismann, T. (2011). Rumination as a predictor of relapse in mindfulness-based cognitive therapy for depression. Psychology and Psychotherapy, 84, 230–236.PubMedCrossRef

Middleton, N., Gunnell, D., Whitley, E., Dorling, D., & Frankel, S. (2001). Secular trends in antidepressant prescribing in the UK, 1975–1998. Journal of Public Health Medicine, 23, 262–267.PubMedCrossRef

National Institute for Health and Clinical Excellence. (2004). Depression: Management of depression in primary and secondary care. National Clinical Practice Guideline Number, 23.

Nolen-Hoeksema, S. (1991). Responses to depression and their effects on the duration of depressive episodes. Journal of Abnormal Psychology, 100, 569–582.PubMedCrossRef

Nolen-Hoeksema, S., & Morrow, J. (1991). A prospective study of depression and posttraumatic stress symptoms after a natural disaster: The 1989 Loma Prieta earthquake. Journal of Personality and Social Psychology, 61, 115–121.PubMedCrossRef

Normann, N., van Emmerik, A. A., & Morina, N. (2014). The efficacy of metacognitive therapy for anxiety and depression: A meta-analytic review. Depression and Anxiety, 31, 402–411.PubMedCrossRef

Papageorgiou, C. (2006). Worry and rumination: Styles of persistent negative thinking in anxiety and depression. In G. C. L. Davey & A. Wells (Eds.), Worry and its psychological disorders: Theory, assessment and treatment (pp. 21–40). Chichester: Wiley.CrossRef

Papageorgiou, C. (2009). Cognitive behaviour therapy, depressive rumination and metacognition. In G. Simos (Ed.), Cognitive behaviour therapy: A guide for the practising clinician (pp. 18–33). East Sussex: Routledge.

Papageorgiou, C., & Wells, A. (2000). Treatment of recurrent major depression with attention training. Cognitive and Behavioral Practice, 7, 407–413.CrossRef

Papageorgiou, C., & Wells, A. (2001). Positive beliefs about depressive rumination: Development and preliminary validation of a self-report scale. Behavior Therapy, 32, 13–26.CrossRef

Papageorgiou, C., & Wells, A. (2003). An empirical test of a clinical metacognitive model of rumination and depression. Cognitive Therapy and Research, 27, 261–273.CrossRef

Papageorgiou, C., & Wells, A. (2004). Nature, functions, and beliefs about depressive rumination. In C. Papageorgiou & A. Wells (Eds.), Depressive rumination: Nature, theory and treatment (pp. 3–20). Chichester: Wiley.

Papageorgiou, C., & Wells, A. (2009). A prospective test of the clinical metacognitive model of rumination and depression. International Journal of Cognitive Therapy, 2, 123–131.CrossRef

Papageorgiou, C., Wells, A., & Meina, L. J. (in preparation). Development and preliminary validation of the Negative Beliefs about Rumination Scale.

Paykel, E. S., Ramana, R., Cooper, Z., Hayhurst, H., Kerr, J., & Barocka, A. (1995). Residual symptoms after partial remission: An important outcome in depression. Psychological Medicine, 25, 1171–1180.PubMedCrossRef

Paykel, E. S., Scott, J., Teasdale, J. D., Johnson, A. L., Garland, A., Moore, R., et al. (1999). Prevention of relapse in residual depression by cognitive therapy: A controlled trial. Archives of General Psychiatry, 56, 829–835.PubMedCrossRef

Prudic, J., Haskett, R. F., Mulsant, B., Malone, K. M., Pettinati, H. M., Stephens, S., et al. (1996). Resistance to antidepressant medications and short-term clinical response to ECT. American Journal of Psychiatry, 153, 985–992.PubMedCrossRef

Riso, L. P., du Toit, P. L., Blandino, J. A., Penna, S., Dacey, S., Duin, J. S., et al. (2003). Cognitive aspects of chronic depression. Journal of Abnormal Psychology, 112, 72–80.PubMedCrossRef

Roberts, J. E., Gilboa, E., & Gotlib, I. H. (1998). Ruminative response style and vulnerability to episodes of dysphoria: Gender, neuroticism, and episode duration. Cognitive Therapy and Research, 22, 401–423.CrossRef

Roelofs, J., Papageorgiou, C., Gerber, R. D., Huibers, M., Peeters, F., & Arntz, A. (2007). On the links between self-discrepancies, rumination, metacognitions, and symptoms of depression in undergraduates. Behaviour Research and Therapy, 45, 1295–1305.PubMedCrossRef

Roth, A., & Fonagy, P. (1996). What works for whom? A critical review of psychotherapy research. New York: Guilford Press.

Sackeim, H. (2001). The definition and meaning of treatment-resistant depression. Journal of Clinical Psychiatry, 62, 10–17.PubMed

Schmaling, K. B., Dimidjian, S., Katon, W., & Sullivan, M. (2002). Response styles among patients with minor depression and dysthymia in primary care. Journal of Abnormal Psychology, 111, 350–356.PubMedCrossRef

Scott, J. (2000). Treatment of chronic depression. New England Journal of Medicine, 342, 1518–1520.PubMedCrossRef

Siegle, G. J., Ghinassi, F., & Thase, M. E. (2007). Neurobehavioral therapies in the 21st century: Summary of an emerging field and an extended example of cognitive control training for depression. Cognitive Therapy and Research, 31, 235–262.CrossRef

Spasojevic, J., & Alloy, L. B. (2001). Rumination as a common mechanism relating depressive risk factors to depression. Emotion, 1, 25–37.PubMedCrossRef

Stimpson, N., Agrawal, N., & Lewis, G. (2002). Randomised controlled trials investigating pharmacological and psychological interventions for treatment-refractory depression: Systematic review. British Journal of Psychiatry, 181, 284–294.PubMedCrossRef

Thase, M. E. (2001). The need for clinically relevant research on treatment-resistant depression. Journal of Clinical Psychiatry, 62, 221–224.PubMedCrossRef

Trivedi, M. H., Rush, A. J., Wisniewski, S. R., Nierenberg, A. A., Warden, D., Ritz, L., et al. (2006). Evaluation of outcomes with citalopram for depression using measurement-based care in STAR*D: Implications for clinical practice. American Journal of Psychiatry, 163, 28–40.PubMedCrossRef

Wells, A. (1990). Panic disorder in association with relaxation induced anxiety: An attention training approach to treatment. Behavior Therapy, 21, 273–280.CrossRef

Wells, A. (2009). Metacognitive therapy for anxiety and depression. New York: Guilford Press.

Wells, A., Fisher, P. L., Myers, S., Wheatley, J., Patel, T., & Brewin, C. R. (2012). Metacognitive therapy in treatment-resistant depression: A platform trial. Behaviour Research and Therapy, 50, 367–373.PubMedCrossRef

Wells, A., & Matthews, G. (1994). Attention and emotion: A clinical perspective. Hove: Erlbaum.

Wells, A., & Papageorgiou, C. (2004). Metacognitive therapy for depressive rumination. In C. Papageorgiou & A. Wells (Eds.), Depressive rumination: Nature, theory and treatment (pp. 259–273). Chichester: Wiley.

Titel: Group Metacognitive Therapy for Severe Antidepressant and CBT Resistant Depression: A Baseline-Controlled Trial
Auteurs: Costas Papageorgiou
Adrian Wells
Publicatiedatum: 01-02-2015
Uitgeverij: Springer US
Gepubliceerd in: Cognitive Therapy and Research / Uitgave 1/2015
Print ISSN: 0147-5916
Elektronisch ISSN: 1573-2819
DOI: https://doi.org/10.1007/s10608-014-9632-x

Bohn Stafleu van Loghum

Deel dit onderdeel of sectie (kopieer de link)

Abstract

Log in om toegang te krijgen

Andere artikelen Uitgave 1/2015

Metacognitions and Thought Control Strategies in Unipolar Major Depression: A Comparison of Currently Depressed, Previously Depressed, and Never-Depressed Individuals

A Randomised Controlled Study of the Effects of the Attention Training Technique on Traumatic Stress Symptoms, Emotional Attention Set Shifting and Flexibility

Metacognitive Therapy Versus Prolonged Exposure in Adults with Chronic Post-traumatic Stress Disorder: A Parallel Randomized Controlled Trial

Metacognition, Responsibility, and Perfectionism in Obsessive–Compulsive Disorder

A Prospective Study of the Association of Metacognitive Beliefs and Processes with Persistent Emotional Distress After Diagnosis of Cancer

How to Deal with Negative Thoughts? A Preliminary Comparison of Detached Mindfulness and Thought Evaluation in Socially Anxious Individuals